SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech & Nutrition informs about disclosure

14 Mar 2023 Evaluate
Emmessar Biotech & Nutrition has informed that Emmessar Technologies, Promoter Company, have acquired 9928 equity shares of the company from March 06, 2023 to March 13, 2023 through open market. The intimation was received by the Company on 14-03-2023. The company also enclosed the disclosure under Regulation, 29(2) of the of SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011.

The above information is a part of company’s filings submitted to BSE.

Emmessar Biotech&Nut Share Price

27.49 0.50 (1.85%)
17-Apr-2026 10:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1689.10
Dr. Reddys Lab 1221.40
Cipla 1239.90
Zydus Lifesciences 946.80
Lupin 2333.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×